Andrew J K Ostor

Summary

Affiliation: Addenbrooke's Hospital
Country: UK

Publications

  1. ncbi Interrater reproducibility of clinical tests for rotator cuff lesions
    A J K Ostor
    Rheumatology Research Unit, Box 194, Hills Road, Cambridge CB2 2QQ, UK
    Ann Rheum Dis 63:1288-92. 2004
  2. ncbi Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis
    Andrew J K Ostor
    Rheumatology Department, Addenbrooke s Hospital, Cambridge, UK
    J Rheumatol 33:622-8. 2006
  3. ncbi The murky waters of the coxibs: a review of the current state of play
    Andrew J K Ostor
    Rheumatology Research Unit, Addenbrooke s Hospital, Hills Road, Cambridge CB2 2QQ, UK
    Inflammopharmacology 13:371-80. 2005
  4. ncbi Diagnosis and relation to general health of shoulder disorders presenting to primary care
    A J K Ostor
    Rheumatology Research Unit, Box 194, Addenbrooke s Hospital, Hills Road, Cambridge CB2 2QQ, UK
    Rheumatology (Oxford) 44:800-5. 2005
  5. ncbi Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab
    Andrew J K Ostor
    Department of Rheumatology, Addenbrooke's Hospital, Cambridge CB2 2QQ
    BMJ 329:1266. 2004
  6. ncbi Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis
    Andrew J K Ostor
    Addenbrooke s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    Clin Rheumatol 27:1343-53. 2008
  7. ncbi Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    Rheumatology (Oxford) 50:518-31. 2011
  8. ncbi The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Poole Hospital NHS Foundation Trust, Poole, UK
    Rheumatology (Oxford) 49:295-307. 2010
  9. ncbi Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
    Laura Campbell
    Department of Medicine, Clinical School, University of Cambridge, Cambridge CB2 0QQ, UK
    Rheumatology (Oxford) 50:552-62. 2011
  10. ncbi Contemporary treatment principles for early rheumatoid arthritis: a consensus statement
    Patrick D W Kiely
    Department of Rheumatology, St Georges Healthcare NHS Trust, London, UK
    Rheumatology (Oxford) 48:765-72. 2009

Collaborators

  • Jonathan C P Roos
  • Christopher J Edwards
  • C A Speed
  • Chris Deighton
  • Nick Curzen
  • Richard J Wakefield
  • Anita Y N Lim
  • Anshuman P Malaviya
  • Sarah L Westlake
  • Muhammad K Nisar
  • Patrick D W Kiely
  • Shweta Bhagat
  • Mark Quinn
  • Taras Gout
  • Laura Campbell
  • Andreas V Hadjinicolaou
  • Patrick Kiely
  • Ernest Choy
  • Janis Baird
  • Alexandra N Colebatch
  • Edwin R Chilvers
  • Brian L Hazleman
  • Alex Kudrin
  • Annabel Kuek
  • Josh Dixey
  • Chen Chen
  • Helen Parfrey
  • Richard A Parker
  • Shweta S Bhagat
  • Allister Taggart
  • David T O'Reilly
  • Philip G Conaghan
  • Peter C Taylor
  • Andrew K Brown
  • Meryl H Griffiths
  • Sathia Thiru
  • Amel Ginawi

Detail Information

Publications24

  1. ncbi Interrater reproducibility of clinical tests for rotator cuff lesions
    A J K Ostor
    Rheumatology Research Unit, Box 194, Hills Road, Cambridge CB2 2QQ, UK
    Ann Rheum Dis 63:1288-92. 2004
    ..Rotator cuff lesions are common in the community but reproducibility of tests for shoulder assessment has not been adequately appraised and there is no uniform approach to their use...
  2. ncbi Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis
    Andrew J K Ostor
    Rheumatology Department, Addenbrooke s Hospital, Cambridge, UK
    J Rheumatol 33:622-8. 2006
    ....
  3. ncbi The murky waters of the coxibs: a review of the current state of play
    Andrew J K Ostor
    Rheumatology Research Unit, Addenbrooke s Hospital, Hills Road, Cambridge CB2 2QQ, UK
    Inflammopharmacology 13:371-80. 2005
    ..This article will attempt to review the data regarding coxibs and make some recommendations regarding their ongoing use...
  4. ncbi Diagnosis and relation to general health of shoulder disorders presenting to primary care
    A J K Ostor
    Rheumatology Research Unit, Box 194, Addenbrooke s Hospital, Hills Road, Cambridge CB2 2QQ, UK
    Rheumatology (Oxford) 44:800-5. 2005
    ..To prospectively evaluate the incidence, spectrum of disease and relation to general health of shoulder disorders in primary care...
  5. ncbi Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab
    Andrew J K Ostor
    Department of Rheumatology, Addenbrooke's Hospital, Cambridge CB2 2QQ
    BMJ 329:1266. 2004
  6. ncbi Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis
    Andrew J K Ostor
    Addenbrooke s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
    Clin Rheumatol 27:1343-53. 2008
    ..Taken together, these data suggest that selective co-stimulation modulation with abatacept may be a viable option for patients who are refractory to both traditional therapies and TNF-alpha antagonists...
  7. ncbi Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
    Rheumatology (Oxford) 50:518-31. 2011
    ..However, the extent to which these agents also reduce cardiovascular disease (CVD) is uncertain. The purpose of this study was to explore the effect of anti-TNF agents on CVD in RA using a systematic literature review...
  8. ncbi The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
    Sarah L Westlake
    Department of Rheumatology, Poole Hospital NHS Foundation Trust, Poole, UK
    Rheumatology (Oxford) 49:295-307. 2010
    ..This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA...
  9. ncbi Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
    Laura Campbell
    Department of Medicine, Clinical School, University of Cambridge, Cambridge CB2 0QQ, UK
    Rheumatology (Oxford) 50:552-62. 2011
    ..To assess the risk of adverse events (AEs) in patients with RA treated with tocilizumab, an IL-6 receptor antibody, in published randomized controlled trials (RCTs)...
  10. ncbi Contemporary treatment principles for early rheumatoid arthritis: a consensus statement
    Patrick D W Kiely
    Department of Rheumatology, St Georges Healthcare NHS Trust, London, UK
    Rheumatology (Oxford) 48:765-72. 2009
    ..RA has a substantial impact on both patients and healthcare systems. Our objective is to advance the understanding of modern management principles in light of recent evidence concerning the condition's diagnosis and treatment...
  11. ncbi Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution
    Annabel Kuek
    Rheumatology Research Unit, Addenbrooke s Hospital, Cambridge, UK
    Postgrad Med J 83:251-60. 2007
    ..For the medical profession, IMID represents a breakthrough in the way pathology is classified. In this burgeoning era of biologic therapy the prospect of complete disease remission is conceivable...
  12. ncbi Biologic agents for rheumatoid arthritis--negotiating the NICE technology appraisals
    Patrick D W Kiely
    Department of Rheumatology, St Georges Healthcare NHS Trust, London SW17 0QT, UK
    Rheumatology (Oxford) 51:24-31. 2012
    ..In this review, we discuss the treatment algorithm published by NICE, and suggest alternatives where perceived deficiencies exist...
  13. ncbi Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review
    Andreas V Hadjinicolaou
    Rheumatology Research Unit, Box 194, Addenbrooke s Hospital, CUHNHSFT, Cambridge CB2 2QQ, UK
    Rheumatology (Oxford) 50:2297-305. 2011
    ..As the use of these drugs increases, clinicians must remain vigilant for potential pulmonary complications and exercise caution in prescribing biologic therapies, particularly to rheumatological patients with pre-existing ILD...
  14. ncbi Disease remission the goal of therapy in rheumatoid arthritis
    Muhammad K Nisar
    Addenbrooke s Hospital, Cambridge
    Practitioner 254:17-21, 2. 2010
    ....
  15. ncbi Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
    Taras Gout
    School of Clinical Medicine, University of Cambridge, Cambridge, UK
    Clin Rheumatol 30:1471-4. 2011
    ..The mechanism of action of IL-6 antagonism in the pathophysiology of diverticular perforation has yet to be elucidated...
  16. ncbi Early diagnosis crucial in ankylosing spondylitis
    Anshuman P Malaviya
    Rheumatology Clinical Research Unit, Addenbrooke s Hospital, Cambridge
    Practitioner 255:21-4, 2. 2011
    ..However, about half these patients need escalation to biologic therapy. Patients with a suspected diagnosis should be referred to secondary care in order to confirm the diagnosis and commence treatment...
  17. ncbi Rheumatoid arthritis and the era of biologic therapy
    Anshuman P Malaviya
    School of Clinical Medicine, University of Cambridge, Cambridge, UK
    Inflammopharmacology 20:59-69. 2012
    ..In addition, we will provide a commentary on the current limitations and unmet needs in this area and discuss the future of biologic intervention...
  18. ncbi Diagnosing joint pain in the older people
    Shweta Bhagat
    Rheumatology Clinical Research Unit, Addenbrooke s Hospital, Cambridge
    Practitioner 254:17-21, 2. 2010
    ..Corticosteroids may be very effective in the elderly, however, prolonged use and/or high dosage may lead to marked toxicity especially osteoporosis and diabetes...
  19. ncbi Necrotizing group A streptococcal periorbital infection following adalimumab therapy for rheumatoid arthritis
    Jonathan C P Roos
    Department of Medicine, University of Cambridge, Cambridge, UK
    Cutan Ocul Toxicol 30:160-2. 2011
    ..2) To identify bacterial species responsible for infection with different forms of biological therapy...
  20. ncbi Orbital cellulitis in a patient receiving infliximab for Ankylosing spondylitis
    Jonathan C P Roos
    Department of Medicine, University of Cambridge, Cambridge, United Kingdom
    Am J Ophthalmol 141:767-9. 2006
    ..To describe a case of orbital cellulitis arising in a patient treated with an anti-TNFalpha agent...
  21. ncbi Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy
    Jonathan C P Roos
    J Rheumatol 34:238-9; author reply 239. 2007
  22. ncbi Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection
    Jonathan C P Roos
    Arthritis Rheum 54:381-2. 2006
  23. ncbi Neurological complications of infliximab
    Jonathan C P Roos
    J Rheumatol 34:236-7; author reply 237-8. 2007
  24. ncbi Sarcoid-like granulomatous disease following etanercept treatment for RA
    Alex Kudrin
    J Rheumatol 34:648-9. 2007